varenicline has been researched along with everolimus in 2 studies
| Studies (varenicline) | Trials (varenicline) | Recent Studies (post-2010) (varenicline) | Studies (everolimus) | Trials (everolimus) | Recent Studies (post-2010) (everolimus) |
|---|---|---|---|---|---|
| 1,597 | 381 | 1,154 | 5,631 | 1,289 | 4,579 |
| Protein | Taxonomy | varenicline (IC50) | everolimus (IC50) |
|---|---|---|---|
| Bile salt export pump | Homo sapiens (human) | 2 | |
| Serine/threonine-protein kinase mTOR | Homo sapiens (human) | 0.0022 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bhattaram, VA; Bonapace, C; Chilukuri, DM; Duan, JZ; Garnett, C; Gobburu, JV; Jang, SH; Kenna, L; Lesko, LJ; Madabushi, R; Men, Y; Powell, JR; Qiu, W; Ramchandani, RP; Tornoe, CW; Wang, Y; Zheng, JJ | 1 |
1 review(s) available for varenicline and everolimus
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for varenicline and everolimus
| Article | Year |
|---|---|
Impact of pharmacometric reviews on new drug approval and labeling decisions--a survey of 31 new drug applications submitted between 2005 and 2006.
Topics: Benzazepines; Clinical Trials as Topic; Cyclosporins; Data Collection; Decision Support Techniques; Disease Progression; Drug Administration Schedule; Drug Approval; Drug Evaluation; Drug Labeling; Echinocandins; Everolimus; Humans; Investigational New Drug Application; Lipopeptides; Lipoproteins; Micafungin; Peer Review; Peptides, Cyclic; Pharmacokinetics; Pharmacology, Clinical; Quinoxalines; Risk Assessment; Sirolimus; Treatment Outcome; United States; United States Food and Drug Administration; Varenicline | 2007 |